MIM
PRCT icon

Monashee Investment Management’s Procept Biorobotics PRCT Stock Holding History

Monashee Investment Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-25,693
Closed -$843K – 76
2023
Q3 		$843K Buy
+25,693
New +$876K 0.35% 60

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Monashee Investment Management's PRCT Position: Q4 2023 in Review

Monashee Investment Management sold out of Procept Biorobotics (PRCT) in Q4 2023, closing a stake of 25,693 shares — an estimated $843K sold.

Monashee Investment Management first reported a position in PRCT in Q3 2023 and held it in 1 quarter. The position peaked at $843K in Q3 2023. 145 funds tracked by Wall St. Rank hold PRCT as of Q4 2023.

  • Monashee Investment Management reported no remaining Procept Biorobotics position as of Q4 2023 after selling out during the quarter.
  • Monashee Investment Management sold 25,693 Procept Biorobotics shares in Q4 2023, an estimated $843K.
  • Monashee Investment Management first reported a position in Procept Biorobotics in Q3 2023 and held it in 1 quarter.
  • Monashee Investment Management's Procept Biorobotics position peaked at $843K in Q3 2023.
  • 145 funds tracked by Wall St. Rank held Procept Biorobotics as of Q4 2023.

Based on Monashee Investment Management's 13F filing for Q4 2023, filed 12 Feb 2024.